mVISE AG
F:C1V
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
mVISE AG
F:C1V
|
DE |
|
B
|
Bechtle AG
DUS:BC8
|
DE |
|
N
|
Nektar Therapeutics
SWB:ITH
|
US |
|
S
|
SpartanNash Co
F:SRJ
|
US |
|
N
|
Nanjing Panda Electronics Co Ltd
SWB:NNJ
|
CN |
|
T
|
Texas Capital Bancshares Inc
XMUN:TCA
|
US |
|
V
|
Valmet Oyj
XMUN:2VO
|
FI |
|
Banyan Tree Holdings Ltd
F:1O7
|
SG |
|
A
|
Ambu A/S
F:547A
|
DK |
Wall St Price Targets
C1V Price Targets Summary
mVISE AG
According to Wall Street analysts, the average 1-year price target for
C1V is 13.92 EUR with a low forecast of 13.79 EUR and a high forecast of 14.33 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is C1V's stock price target?
Price Target
13.92
EUR
According to Wall Street analysts, the average 1-year price target for
C1V is 13.92 EUR with a low forecast of 13.79 EUR and a high forecast of 14.33 EUR.
What is the Revenue forecast for mVISE AG?
Projected CAGR
-11%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is -11%.